The new SARCLISA J-code J9227 is now available, effective October 1, 2020, to be used for reimbursement claims. Refer to the Billing and Coding Guide on the Resources page for additional details. MAT-US-2018558-v1.0-08/2020


Helpful Links for Your Patients

Below you will find links to advocacy organizations that offer support to patients with relapsed refractory multiple myeloma and their caregivers.

Back to topTop FAQs